Understanding how beta-amyloid builds up in the brain of Parkinson's disease patients
Build-up of beta-amyloid in the brain in Parkinson's disease
This study is looking at how a substance called amyloid beta builds up in the brains of people with Parkinson's disease as they start to experience dementia, and it aims to find out how this buildup happens and what role blood cells and inflammation play in the process.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Universidad Central Del Caribe NIH-funded |
| Lab location | 1 site (Bayamon, United States) |
| Project ID | NIH-11089778 on NIH RePORTER |
What this research studies
This research investigates the accumulation of amyloid beta (Aβ) in the brains of patients with Parkinson's disease, particularly as they develop dementia. It aims to understand the mechanisms behind this buildup, focusing on the role of platelets and inflammation in the brain. By examining how Aβ interacts with blood vessels and the potential damage it causes, the study seeks to uncover new insights into the progression of Parkinson's disease dementia. The research involves both laboratory experiments and analysis of patient samples to identify key factors contributing to Aβ accumulation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease, particularly those experiencing cognitive decline or dementia.
Not a fit: Patients with early-stage Parkinson's disease who do not yet exhibit signs of dementia may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing or preventing dementia in Parkinson's disease patients.
How similar studies have performed: Previous research has shown that targeting amyloid beta in Alzheimer's disease has potential, suggesting that similar approaches in Parkinson's disease may also yield beneficial results.
Where this research is happening
Bayamon, United States
- Universidad Central Del Caribe — Bayamon, United States (Active)
Researchers
- Principal investigator: Inyushin, Mikhail — Universidad Central Del Caribe
- Study coordinator: Inyushin, Mikhail
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.